Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
483.96
-10.65 (-2.15%)
Nov 14, 2024, 4:00 PM EST - Market closed
Vertex Pharmaceuticals Operating Expense Breakdown
History
Date | Acquired In-Process Research and Development | Research and Development | Selling, General, and Administrative | Change in Value of Contingent Consideration |
---|---|---|---|---|
Jun 30, 2024 | 4.60B | 3.39B | 1.35B | -48.70M |
Mar 31, 2024 | 256.80M | 3.21B | 1.24B | -49.80M |
Dec 31, 2023 | 527.10M | 3.16B | 1.14B | -51.60M |
Sep 30, 2023 | 531.90M | 3.03B | 1.03B | 500.00K |
Jun 30, 2023 | 509.20M | 2.87B | 1.02B | -3.30M |
Mar 31, 2023 | 460.60M | 2.68B | 970.60M | -51.90M |
Dec 31, 2022 | 115.50M | 2.54B | 944.70M | -57.50M |
Sep 30, 2022 | 221.10M | 2.41B | 995.50M | -61.30M |
Jun 30, 2022 | 218.80M | 2.23B | 946.90M | -57.50M |
Mar 31, 2022 | 1.12B | 2.08B | 926.20M | -6.70M |
Dec 31, 2021 | 1.11B | 1.94B | 840.10M | -3.10M |
Sep 30, 2021 | 985.10M | 1.84B | 733.74M | -600.00K |
Jun 30, 2021 | 958.40M | 1.86B | 720.09M | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.